Aspire Private Capital’s Omega Healthcare OHI Stock Holding History

Aspire Private Capital’s Portfolio OHI Stock Details OHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,175	Closed	-$88.5K	–	479
2024 Q3	$88.5K	Buy	2,175 +23	+1%	+$870	0.02%	202
2024 Q2	$73.7K	Buy	2,152 +26	+1%	+$819	0.02%	212
2024 Q1	$67.3K	Buy	2,126 +27	+1%	+$821	0.02%	216
2023 Q4	$64.4K	Buy	2,099 +25	+1%	+$802	0.02%	205
2023 Q3	$68.8K	Buy	2,074 +24	+1%	+$767	0.02%	190
2023 Q2	$62.9K	Buy	2,050 +724	+55%	+$20.9K	0.02%	190
2023 Q1	$36.4K	Buy	1,326 +9	+0.7%	+$250	0.01%	237
2022 Q4	$36.8K	Buy	1,317 +1,030	+359%	+$31.1K	0.01%	224
2022 Q3	$8K	Buy	287 +6	+2%	+$188	﹤0.01%	370
2022 Q2	$8K	Buy	281 +175	+165%	+$4.98K	﹤0.01%	362
2022 Q1	$3K	Buy	+106	New	+$3.13K	﹤0.01%	463

Other funds holding OHI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Aspire Private Capital's OHI Position: Q4 2024 in Review

Aspire Private Capital sold out of Omega Healthcare (OHI) in Q4 2024, closing a stake of 2,175 shares — an estimated $88.5K sold.

Aspire Private Capital first reported a position in OHI in Q1 2022 and held it in 11 quarters. The position peaked at $88.5K in Q3 2024. 622 funds tracked by Wall St. Rank hold OHI as of Q4 2024.

Aspire Private Capital reported no remaining Omega Healthcare position as of Q4 2024 after selling out during the quarter.
Aspire Private Capital sold 2,175 Omega Healthcare shares in Q4 2024, an estimated $88.5K.
Aspire Private Capital first reported a position in Omega Healthcare in Q1 2022 and held it in 11 quarters.
Aspire Private Capital's Omega Healthcare position peaked at $88.5K in Q3 2024.
622 funds tracked by Wall St. Rank held Omega Healthcare as of Q4 2024.

Based on Aspire Private Capital's 13F filing for Q4 2024, filed 17 Jan 2025.